XML 17 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenue $ 46,079 $ 56,419 $ 119,810 $ 141,137
Costs and expenses:        
FI Share and other third-party costs 27,971 32,470 70,920 79,094
Delivery costs 3,498 3,070 10,403 9,686
Sales and marketing expense 11,432 11,074 32,805 31,458
Research and development expense 4,627 3,018 12,444 8,741
General and administration expense 12,757 12,218 35,235 27,558
Depreciation and amortization expense 1,933 1,167 5,809 3,181
Total costs and expenses 62,218 63,017 167,616 159,718
Operating loss (16,139) (6,598) (47,806) (18,581)
Other Income and Expenses [Abstract]        
Interest Income (Expense), Net (283) (218) (9) (860)
Other Nonoperating Income (Expense) 1,066 (931) (830) (1,130)
Nonoperating Income (Expense), Total 783 (1,149) (839) (1,990)
Loss before income taxes (15,356) (7,747) (48,645) (20,571)
Income Tax Expense (Benefit) 0 0 0 0
Net loss (15,356) (7,747) (48,645) (20,571)
Net loss attributable to common stockholders $ (15,356) $ (7,747) $ (48,645) $ (20,571)
Net loss per share attributable to common stockholders, basic and diluted (in USD per share) $ (0.56) $ (0.33) $ (1.80) $ (0.90)
Weighted-average common shares outstanding, basic and diluted (in shares) 27,343 23,561 27,048 22,936